Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q2 2022 · 10-Q
Revenue$65.22M$65.22M+43.8% vs Q2 2021 Net Income-$95.65M-$95.65MN/M vs Q2 2021 EPS Diluted-$0.80-$0.80N/M vs Q2 2021 Operating Income-$88,316,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$105,205,000N/M Margins · derivedOperating margin-135.4%+59.8 pt vs Q2 2021
Net margin-146.6%+112.0 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 4, 2022 · 35 d after period end